LivaNova (NASDAQ:LIVN – Get Free Report) had its target price lifted by equities research analysts at Barclays from $105.00 to $120.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 31.36% from the stock’s previous close.
A number of other equities analysts have also weighed in on the stock. Zacks Research lowered shares of LivaNova from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 19th. Wall Street Zen downgraded shares of LivaNova from a “strong-buy” rating to a “buy” rating in a report on Saturday. Piper Sandler reiterated an “overweight” rating and issued a $90.00 price target (up from $87.00) on shares of LivaNova in a report on Wednesday, September 2nd. Needham & Company LLC boosted their price target on shares of LivaNova from $93.00 to $112.00 and gave the stock a “buy” rating in a research note on Wednesday, November 4th. Finally, Stifel Nicolaus set a $85.00 price target on shares of LivaNova in a research note on Wednesday, August 5th. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $101.22.
Check Out Our Latest Research Report on LivaNova
LivaNova Price Performance
LIVN stock traded up $1.36 during midday trading on Monday, hitting $91.36. The company’s stock had a trading volume of 51,574 shares, compared to its average volume of 742,800. The company has a quick ratio of 1.22, a current ratio of 1.46 and a debt-to-equity ratio of 0.22. LivaNova has a 12 month low of $49.83 and a 12 month high of $99.38. The company has a 50 day moving average of $79.27 and a two-hundred day moving average of $73.54. The firm has a market capitalization of $5.03 billion, a price-to-earnings ratio of 30.42 and a beta of 0.91.
LivaNova (NASDAQ:LIVN – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.17. The firm had revenue of $393.15 million for the quarter, compared to analysts’ expectations of $381.13 million. LivaNova had a net margin of 13.01% and a return on equity of 16.10%. The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.11 earnings per share. On average, analysts expect that LivaNova will post 3.79 EPS for the current year.
Insider Activity at LivaNova
In other LivaNova news, Director Brooke Story sold 2,300 shares of the firm’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $81.42, for a total transaction of $187,266.00. Following the completion of the transaction, the director owned 7,488 shares in the company, valued at $609,672.96. This trade represents a 23.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Francesco Bianchi sold 3,500 shares of LivaNova stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $78.01, for a total value of $273,035.00. Following the completion of the sale, the director directly owned 4,434 shares in the company, valued at approximately $345,896.34. The trade was a 44.11% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 7,450 shares of company stock valued at $591,839 in the last 90 days. 0.35% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On LivaNova
A number of hedge funds have recently bought and sold shares of LIVN. Allworth Financial LP lifted its position in LivaNova by 93.5% during the second quarter. Allworth Financial LP now owns 298 shares of the company’s stock valued at $25,000 after purchasing an additional 144 shares during the last quarter. Farther Finance Advisors LLC grew its stake in shares of LivaNova by 59.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 452 shares of the company’s stock worth $35,000 after buying an additional 169 shares in the last quarter. State of Michigan Retirement System increased its holdings in shares of LivaNova by 1.5% in the 1st quarter. State of Michigan Retirement System now owns 13,111 shares of the company’s stock worth $833,000 after buying an additional 200 shares during the last quarter. Hohimer Wealth Management LLC increased its holdings in shares of LivaNova by 5.4% in the 3rd quarter. Hohimer Wealth Management LLC now owns 4,277 shares of the company’s stock worth $327,000 after buying an additional 219 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of LivaNova by 12.5% in the 3rd quarter. GAMMA Investing LLC now owns 2,068 shares of the company’s stock worth $158,000 after buying an additional 230 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.
About LivaNova
See Also
- Five stocks we like better than LivaNova
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.
